Medical and surgical therapies for pain associated with endometriosis

被引:39
作者
Winkel, CA [1 ]
Scialli, AR [1 ]
机构
[1] Georgetown Univ Hosp, Dept Obstet & Gynecol, Washington, DC 20007 USA
来源
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE | 2001年 / 10卷 / 02期
关键词
D O I
10.1089/152460901300039485
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Endometriosis is a common condition for which a number of treatments have been proposed. Medical treatments are based on the hormonal responsiveness of endometriosis implants. These therapies include progestins (with or without estrogens), androgens, and gonadotropin-releasing hormone (GnRH) analogs. Surgical treatments may include hysterectomy with oophorectomy or organ-sparing surgery involving ablation or resection of visible lesions of endometriosis and restoration of pelvic anatomy. There are no studies that directly compare the effectiveness or adverse effects of medical therapy and surgical therapy. Studies on medical therapy compare different treatments with placebo or with other active treatments. Hormone-based therapies for endometriosis show 80%-100% effectiveness in relief of pelvic pain over a 6-month course of therapy. Serious adverse outcomes after medical therapy are unusual. Studies on surgical therapy are largely anecdotal, with noncomparative reports on a variety of surgical methods. A few comparative surgical studies have been reported. Because of the noncomparative nature of many of the surgical studies, the use of combinations of surgical procedures and techniques in the reported studies, and the reporting of results from surgeons with an unusually high level of technical skill, the gynecological practitioner has little basis in the literature for assessing the optimum surgical approach. Surgical complications are believed to be underreported and may be related to how aggressive a surgical procedure is undertaken.
引用
收藏
页码:137 / 162
页数:26
相关论文
共 116 条
[91]  
RUGGI C, 1899, SIMPATICECTOMIA ADDO
[92]  
Sampson JA, 1924, Surg Gynecol Obstet, V38, P287
[93]   Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States [J].
Schwingl, PJ ;
Ory, HW ;
Visness, CM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (01) :241-249
[94]  
SCIALLI AR, 1993, FERTIL STERIL, V59, P674
[95]  
Scialli AR, 1999, AM J MANAG CARE, V5, pS327
[96]   MASSIVE NORETHYNODREL THERAPY IN TREATMENT OF ENDOMETRIOSIS [J].
SCOTT, JW ;
BRASS, P .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1966, 95 (08) :1166-&
[97]  
Sen S K, 1967, J Natl Med Assoc, V59, P327
[98]   NAFARELIN IN THE TREATMENT OF PELVIC PAIN CAUSED BY ENDOMETRIOSIS [J].
SHAW, RW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 162 (02) :574-576
[99]  
SHAW RW, 1992, FERTIL STERIL, V58, P265
[100]  
Speroff L., 1996, CLIN GUIDE CONTRACEP